NSIM
IMMU

North Star Investment Management’s Immunomedics Inc IMMU Stock Holding History

North Star Investment Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,000
Closed -$106K – 1098
2019
Q4 		$106K Hold
5,000
– – 0.01% 427
2019
Q3 		$66K Buy
+5,000
New +$73.5K 0.01% 499
2019
Q1 		– Sell
-3,500
Closed -$50K – 1106
2018
Q4 		$50K Buy
+3,500
New +$69.5K 0.01% 518

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

North Star Investment Management's IMMU Position: Q1 2020 in Review

North Star Investment Management sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 5,000 shares — an estimated $106K sold.

North Star Investment Management first reported a position in IMMU in Q4 2018 and held it in 3 quarters. The position peaked at $106K in Q4 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • North Star Investment Management reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • North Star Investment Management sold 5,000 Immunomedics Inc shares in Q1 2020, an estimated $106K.
  • North Star Investment Management first reported a position in Immunomedics Inc in Q4 2018 and held it in 3 quarters.
  • North Star Investment Management's Immunomedics Inc position peaked at $106K in Q4 2019.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on North Star Investment Management's 13F filing for Q1 2020, filed 23 Apr 2020.